Olympus Cholesterol Reagent
by Olympus Corp. 510(k)
Active
510(k) K925603
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK925603 | Date8 Feb 1993 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
-
- Terminated Z-1025-2015
N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations for the treatment of acetaminophen overdose, interferes with the assays for these analytes: Cholesterol OSR6X16, Uric Acid OSR6X98, Lactate OSR6X93, and Lipase OSR6X30. NAC interference may lead to falsely low results.
Specification
- 510(k) Number
- FDA Product Code
- CHH
- Device Class
- Class I
- Regulation
- 21 CFR Part 862.1175
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent